We have developed a qualitative method to assay for the presence of 2-deoxystreptamine in hydrolysates of crude aminoglycoside preparations using a 2-deoxystreptamine-requiring idiotrophic mutant. The assay involves (i) incubation of a 2-deoxystreptamine-requiring mutant with 1 mg of a hydrolyzed preparation from a crude unknown antibiotic mixture per ml, and (ii) examination of the resultant incubation mixture for production of antibiotic(s) by disk assay.
A 2-deoxystreptamine (2-DOS)-requiring idiotrophic mutant 1550F (3), derived from Micromonospora inyoensis NRRL 3292 (4), was used to detect the presence of 2-DOS in hydrolysates of crude antibiotic mixtures. Mutant 1550F is blocked in a step leading to 2-DOS; consequently, it is incapable of producing sisomicin without 2-DOS supplemented exogenously. Sisomicin is produced when the mutant is incubated with 2-DOS or a hydrolysate of a 2-DOSbearing antibiotic.
In control experiments, 2-DOS or paromamine (2-DOS-bearing pseudo-disaccharide) was added to 50 ml of a 48-h fermentation broth in a 250-ml flask (1) at a final concentration of 300 ,ug/ml, and the incubation mixture was shaken at 370 rpm at 28°C. Samples (5 ml) were withdrawn after an additional 24, 48, 72, 96, or 120 h of incubation, and the progression of antibiotic synthesis was followed by bioassay of the samples against Staphylococcus aureus ATCC 6538P (2) . When the bioassay values were plot- ted against time, the rate of antibiotic synthesis by addition of 2-DOS or paromamine appeared linear up to the latest time point which we studied (120 h after addition of the precursors) (Fig. 1) .
Based on bioautographic analysis, mutant 155OF yielded sisomicin when incubated with either 2-DOS or paromamine. However, the rate of antibiotic synthesis after addition of paromamine was slower than after addition of 2-DOS. It is not known whether the added paromamine is transported into the cells directly or first hydrolyzed to 2-DOS. If the latter, the rate of antibiotic synthesis after addition of paromamine would be expected to be less than after direct addition of 2-DOS.
To determine whether this procedure would detect 2-DOS in crude antibiotic mixtures, the 2-DOS-requiring mutant 1550F was incubated in the presence of acid-hydrolyzed preparations of a variety of crude antibiotic mixtures. The conditions chosen based on the aforementioned control experiments were (i) addition of 1 mg of a hydrolyzed preparation from a crude antibiotic mixture per ml to a 48-h fermentation broth (50 ml) of the mutant, (ii) incubation for an additional 120 h, and (iii) examination of the resultant incubation mixture for production of antibiotics by disk assay. As positive controls we detennined that antibiotics were produced when the 2-DOS-requiring mutant was incubated with hydrolysates of crude gentamicin, sisomicin, verdamicin, or antibiotic G-52 fermentation concentrates. However, when we incubated the mutant with hydrolyzed preparations of non-2-DOSbearing antibiotic fermentation concentrates, including fortimicin, no antibiotic activity was produced (Table 1) .
These results confinned that the qualitative assay method could usefully identify hydrolysates of crude antibiotic concentrates containing 2-DOS. 
